*Shogo Mase^1,2, Yuko Sekino¹, Tomoaki Shirao^2,3, Toshinari Mitsuoka¹ (1. Endowed Laboratory of Human Cell-Based Drug Discovery, Graduate School of Pharmaceutical Sciences, The University of Tokyo, Tokyo, Japan, 2. Department of Neurobiology and Behavior, Gunma University Graduate School of Medicine, Maebashi, Japan, 3. AlzMed, Inc.)

*Kazunori Kanemaru¹, Junji Suzuki², Isamu Taiko^1,3, Masamitsu Iino¹ (1. Div. Mol. Cell Pharmacol., Nihon Univ. Sch. Med., 2. Dept. Physiol., UCSF, 3. Dept. Physiol., Nihon Univ. Sch. Med.)

*Xuefeng Wu¹, Toru Suzuki¹, Masaru Mimura¹, Kenji Tanaka¹ (1. Keio University)

*Yasuyuki Osanai^1,2, Tobias David Merson², Nobuhiko Ohno¹ (1. Jichi Medical University, 2. Monash University)